November 14, 2017 / 9:35 PM / 5 days ago

BRIEF-Asterias Biotherapeutics reports Q3 loss of $0.14 per share

Nov 14 (Reuters) - Asterias Biotherapeutics Inc

* Asterias Biotherapeutics reports third quarter financial results and recent developments

* Q3 loss per share $0.14

* Q3 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S

* Q3 revenue $1.7 million versus i/b/e/s view $1.5 million

* Continues to execute on key clinical programs and streamline cost structure

* As of September 30, 2017, combined total of cash, cash equivalents, and available-for-sale securities totaled $20.7 million​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below